Covered recipient · General Payments record
CAROLINE J BUHION
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$5,313.74
- Reported across 44 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.03 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $179.64 | 4 |
| Acerta Pharma LLC | $58.30 | 2 |
| Genmab U.S., Inc. | $48.24 | 2 |
| Kite Pharma, Inc. | $33.56 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.95 | 1 |
| Alexion Pharmaceuticals, Inc. | $25.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.00 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106845000 | CMS |
| ABBVIE INC. | $146.48 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106845002 | CMS |
| ABBVIE INC. | $13.16 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106845004 | CMS |
| ABBVIE INC. | $10.00 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106845006 | CMS |
| Alexion Pharmaceuticals, Inc. | $25.34 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093973442 | CMS |
| AstraZeneca Pharmaceuticals LP | $30.59 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104410089 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.71 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105212839 | CMS |
| Genmab U.S., Inc. | $13.33 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126834684 | CMS |
| Genmab U.S., Inc. | $34.91 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126834686 | CMS |
| Kite Pharma, Inc. | $33.56 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128609701 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.95 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144972708 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.